English
Oracle Corporation Purchases MMP Portfolio License
CARLSBAD, Calif., November 9, 2012--Patriot Scientific Corporation (OTCBB: PTSC) announced today Oracle Corporation has purchased an MMP(TM) Portfolio license.
About Patriot Scientific Corporation
Headquartered in Carlsbad, California, Patriot Scientific Corporation (PTSC) is the co-owner of the Moore Microprocessor Patent Portfolio(TM). For more information on PTSC, visit www.ptsc.com.
About the MMP Portfolio(TM)
The MMP Portfolio includes US patents as well as their European and Japanese counterparts, which cover techniques that enable higher performance and lower cost designs essential to consumer and commercial digital systems ranging from PCs, cell phones and portable music players to communications infrastructure, medical equipment and automobiles.
|
||||||
Related News
- Cummins Inc. Purchases MMP Portfolio(TM) License, According to Patriot Scientific Corporation
- Patriot Scientific's Planned Momentum Increases as Lexmark Purchases MMP(TM) Patent Portfolio License
- Nikon Purchases MMP(TM) Portfolio License; Licensing Program for Fundamental Patents Continues to Attract Support of World's Top Intellectual Property Companies
- Unisys Corporation Purchases Moore Microprocessor Patent Portfolio License
- ASUSTeK Purchases Moore Microprocessor Patent Portfolio License
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design
|
E-mail This Article | 
|
|
Printer-Friendly Page |